top of page

Kaiyuan Wang

Research Fellow

Research interest

Drug delivery & Nanomedicine

Education background

Ph.D., Pharmaceutics, Shenyang Pharmaceutical University, 2020-2023

M.Sc., Pharmaceutics, Shenyang Pharmaceutical University, 2017-2020

B.Sc., Pharmaceutics, Shenyang Pharmaceutical University, 2013-2017

Liang Zhao_edited_edited.jpg

Publication

  1. Kaiyuan Wang#; Xuanbo Zhang#; Hao Ye#; Xia Wang; Zhijin Fan; Qi Lu; Songhao Li; Jian Zhao; Shunzhe Zheng; Zhonggui He*; Qianqian Ni*; Xiaoyuan Chen*; Jin Sun*; Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy. Nature Communications, 14 (2023) 6748.

  2. Kaiyuan Wang#; Yang Li#; Xia Wang#; Zhijun Zhang; Liping Cao; Xiaoyuan Fan; Bin Wan; Fengxiang Liu; Xuanbo Zhang; Zhonggui He; Yingtang Zhou*; Dong Wang*; Jin Sun*; Xiaoyuan Chen*; Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumor through cGAS-STING pathway activation. Nature Communications, 14 (2023) 2950.

  3. Kaiyuan Wang#; Hao Ye#; Xuanbo Zhang; Xia Wang; Bin Yang; Cong Luo; Zhiqiang Zhao; Jian Zhao; Qi Lu; Haotian Zhang; Qiming Kan; Yongjun Wang; Zhonggui He; Jin Sun*; An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition. Biomaterials, 257 (2020) 120224.

  4. Kaiyuan Wang#; Bin Yang#; Hao Ye; Xuanbo Zhang; Hang Song; Xia Wang; Na Li; Lin Wei; Yu Wang; Haotian Zhang; Qiming Kan; Zhonggui He; Dun Wang ; Jin Sun ; Self-strengthened oxidation-responsive bioactivating prodrug nanosystem with sequential and synergistically facilitated drug release for treatment of breast cancer. ACS Applied Materials & Interfaces, 11(21) (2019) 18914-18922.

  5. Hao Ye#; Kaiyuan Wang#; Jian Zhao; Qi Lu; Menglin Wang; Bingjun Sun; Yang Shen; Hongchen Liu*; Salvador Pané; Xiangzhong Chen*; Zhonggui He*; Jin Sun*; In Situ Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy. ACS Nano, 17 (11) (2023) 10637-10650.

  6. Yifei He#; Kaiyuan Wang#; Yutong Lu; Bingjun Sun; Jin Sun*; Wei Liang*; Monensin Enhanced Generation of Extracellular Vesicles as Transfersomes for Promoting Tumor Penetration of Pyropheophorbide-a from Fusogenic Liposome. Nano Letters, 22(3) (2022) 1415-1424.

  7. Qi Lu#; Hao Ye#; Kaiyuan Wang#; Jian Zhao; Helin Wang; Jiaxuan Song; Xiaoyuan Fan; Yutong Lu; Liping Cao; Bin Wan; Haotian Zhang; Zhonggui He; Jin Sun*; Bioengineered Platelets Combining Chemotherapy and Immunotherapy for Postsurgical Melanoma Treatment: Internal Core-Loaded Doxorubicin and External Surface-Anchored Anti-PD-L1 Antibody Backpacks. Nano Letters, 22(7) (2022) 3141-3150.

  8. Xiaoyuan Fan#; Kaiyuan Wang#; Qi Lu; Yutong Lu; Jin Sun*; Cell‐Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy. Small, 19(4) (2023) 2205166.

  9. Xiaoyuan Fan#; Kaiyuan Wang#; Qi Lu; Yutong Lu; Fengxiang Liu; Lu Li; Songhao Li; Hao Ye; Jian Zhao; Liping Cao; Haotian Zhang; Zhonggui He; Jin Sun*; Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment. Acta Biomaterialia, 154 (2022) 412-423.

bottom of page